Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach

被引:24
作者
De Maeyer, J. H. [1 ,2 ]
Schuurkes, J. A. J. [1 ]
Lefebvre, R. A. [2 ]
机构
[1] Movetis NV, B-2300 Turnhout, Belgium
[2] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
关键词
5-HT4; receptor; proximal stomach; left atrium; desensitization; tachyphylaxis; prucalopride; M0003; COLON CIRCULAR MUSCLE; ADRENOCEPTOR BLOCKADE; CHOLINERGIC NERVES; PROXIMAL STOMACH; TROPONIN-I; AGONISTS; PHOSPHORYLATION; RAT; BINDING; PROTEIN;
D O I
10.1111/j.1476-5381.2008.00007.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The time dependency of the effect of 5-HT4 receptor agonists depends on many specific regulatory mechanisms, which vary between tissues. This has important implications with regard to the effects of endogenous 5-HT, as well as to the clinical use of 5-HT4 receptor agonists, and might contribute to tissue selectivity of agonists. The progression and desensitization of 5-HT4 receptor-mediated responses were evaluated in an organ bath set-up using two, clinically relevant, porcine in vitro models: gastric cholinergic neurotransmission and atrial contractility. Exposure of gastric tissue to 5-HT or to the selective 5-HT4 receptor agonists prucalopride and M0003 results in a sustained non-transient effect during exposure; after washout, the response to a subsequent challenge with 5-HT shows no clear desensitization. Incubation of left atrial tissue with 5-HT resulted in a transient response, leading after washout to a marked desensitization of the subsequent response to 5-HT. The selective 5-HT4 receptor agonists prucalopride and M0003 induce only very weak atrial responses whereas they are very effective in desensitizing the atrial response to 5-HT. The observations also suggest that the properties of prucalopride and M0003 to bind to and/or activate the 5-HT4 receptor differ from those of 5-HT. This difference might have contributed to the observed desensitization. The high potency of prucalopride and M0003 in desensitizing the response to 5-HT together with their low efficacy in the atrium emphasizes the cardiac safety of this class of 5-HT4 receptor agonists.
引用
收藏
页码:362 / 376
页数:15
相关论文
共 50 条
  • [21] Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium
    Gergs, Ulrich
    Neumann, Joachim
    Simm, Andreas
    Silber, Rolf-Edgar
    Remmers, Freerk Ole
    Laeer, Stephanie
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (04) : 349 - 359
  • [22] Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro
    Lefebvre, Romain A.
    Van Colen, Inge
    Pauwelyn, Vicky
    De Maeyer, Joris H.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 781 : 76 - 82
  • [23] Multivalent ligands for the serotonin 5-HT4 receptor
    Castriconi, Federica
    Paolino, Marco
    Donati, Alessandro
    Giuliani, Germano
    Anzini, Maurizio
    Mennuni, Laura
    Sabatini, Chiara
    Lanza, Marco
    Caselli, Gianfranco
    Makovec, Francesco
    Sbraccia, Maria
    Molinari, Paola
    Costa, Tommaso
    Cappelli, Andrea
    MEDCHEMCOMM, 2017, 8 (03) : 647 - 651
  • [24] 5-HT-induced, 5-HT3 receptor-mediated, and ruthenium red- and capsaicin-sensitive positive chronotropic effects in the isolated guinea pig atrium
    Nishio, H
    Morimoto, Y
    Hisaoka, K
    Nakata, Y
    Watanabe, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 89 (03) : 242 - 248
  • [25] Human 5-HT4 receptor stimulation in atria of transgenic mice
    Gergs, Ulrich
    Boeckler, Anne
    Ebelt, Henning
    Hauptmann, Steffen
    Keller, Nicolas
    Otto, Volker
    Poenicke, Klaus
    Schmitz, Wilhelm
    Neumann, Joachim
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (05) : 357 - 367
  • [26] Cloning and expression of a human serotonin 5-HT4 receptor cDNA
    VandenWyngaert, I
    Gommeren, W
    Verhasselt, P
    Jurzak, M
    Leysen, J
    Luyten, W
    Bender, E
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (05) : 1810 - 1819
  • [27] Prokinetic actions of luminally acting 5-HT4 receptor agonists
    Konen, John R.
    Haag, Melody M.
    Guseva, Daria
    Hurd, Molly
    Linton, Alisha A.
    Lavoie, Brigitte
    Kerrigan, Colleen B.
    Joyce, Emily
    Bischoff, Stephan C.
    Swann, Steve
    Griffin, Luana
    Matsukawa, Jun
    Falk, Matthew D.
    Gibson, Tony S.
    Hennig, Grant W.
    Wykosky, Jill
    Mawe, Gary M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (04)
  • [28] Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i)
    Brattelid, T
    Kvingedal, AM
    Krobert, KA
    Andressen, KW
    Bach, T
    Hystad, ME
    Kaumann, AJ
    Levy, FO
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (06) : 616 - 628
  • [29] Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i)
    Trond Brattelid
    Ane M. Kvingedal
    Kurt A. Krobert
    Kjetil W. Andressen
    Trond Bach
    Marit E. Hystad
    Alberto J. Kaumann
    Finn Olav Levy
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 616 - 628
  • [30] Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT4 receptor agonists
    Itoh, K
    Kanzaki, K
    Ikebe, T
    Kuroita, T
    Tomozane, H
    Sonda, S
    Sato, N
    Haga, K
    Kawakita, T
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (04) : 329 - 341